MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
September 27, 2005
W.D. Crotty
An Outsourcing Winner Jabil Circuit turns in another outstanding quarter, and some see an even brighter future. Analysts expect earnings to grow at 25% a year for the next five years at the circuit-board manufacturer. mark for My Articles similar articles
The Motley Fool
June 22, 2006
Dan Bloom
Jabil Falls Off the Track Jabil Circuit had a rough quarter. Is an improvement coming? Investors, this stock may be worth a look, but you should perform your due diligence. mark for My Articles similar articles
The Motley Fool
June 22, 2005
W.D. Crotty
Jabil's Sparkling Circuits Given its industry environment, the circuit-board maker posted strong operating margins: 3.8% in the latest quarter and 3.5% on a trailing annual basis. Investors, take note. mark for My Articles similar articles
The Motley Fool
June 26, 2007
Anders Bylund
Wall Street Goes Ga-Ga for Jabil If you're interested in circuit boards, you might do better with Jabil rival Flextronics or quick-release specialist TTM Technologies. mark for My Articles similar articles
The Motley Fool
March 27, 2007
Dan Bloom
Tough Times at Jabil Weakening in the consumer business is going to derail Jabil Circuit's growth. Investors should be in no hurry to jump into these shares. mark for My Articles similar articles
The Motley Fool
September 30, 2009
Anders Bylund
This Ignored Stock Deserves Some Attention It's easy to forget the middlemen of the tech industry. But then you're missing out on both dividends and price gains. mark for My Articles similar articles
The Motley Fool
October 10, 2006
Matthew Crews
Solectron Is Still Turning Investors, until Solectron can return gross margins to the previous 9% to 10% levels of the late 1990s, it will surely remain a turnaround story -- turning around and around and around. mark for My Articles similar articles
The Motley Fool
October 8, 2007
Anders Bylund
3 Stocks That Missed the Mark These three companies overpromised and underdelivered in their quarterly reports. Is it a signal to sell them, or are they turnaround candidates: Walgreen... RPM International... SMART Modular Technologies... mark for My Articles similar articles
The Motley Fool
September 1, 2011
Seth Jayson
1 Reason Jabil Circuit May Be Headed for a Slowdown Jabil Circuit seems to be handling inventory well enough overall, but the individual segments raise some new concerns that you'll want to check out further. mark for My Articles similar articles
The Motley Fool
September 29, 2010
Anders Bylund
How Jabil Is Becoming Best of Breed Jabil Circuit is in the midst of an ambitious recasting of its business model. We should forgive the electronics manufacturer and circuit board maker for missing an estimate or two under these circumstances. mark for My Articles similar articles
The Motley Fool
December 21, 2011
Anders Bylund
Jabil's Drop Is Your Opportunity Jabil has figured out how to stay profitable even when sales growth is slowing down. mark for My Articles similar articles
The Motley Fool
October 26, 2011
Alex Dumortier
Buy Into Jabil's Share Buyback Whether management knows it or not, Jabil Circuit shares look cheap. mark for My Articles similar articles
The Motley Fool
September 22, 2006
Ryan Fuhrmann
More in Store at Rite Aid? The retail pharmacy posted strong second-quarter sales, and an acquisition could help long-term results. Investors, take note. mark for My Articles similar articles
The Motley Fool
March 23, 2011
Anders Bylund
After the Earthquake, One Manufacturer Shines Jabil's shares jumped as much as 12.5% while filling an average day's trading volume in the first 30 minutes after the opening bell after outpacing Wall Street expectations. mark for My Articles similar articles
The Motley Fool
June 16, 2006
Rich Smith
Foolish Forecast: Testing Circuit City The retailer's stock is up 70% over the last year, and for all the analysts' skepticism, no one on Wall Street seems to think this company has seen its best days yet. Come Monday morning, we'll find out who's right, when Circuit City reports its fiscal first quarter 2007 results. mark for My Articles similar articles
The Motley Fool
April 13, 2007
Ryan Fuhrmann
Rite Aid's Right-Size Ambitions If the retail pharmacy chain can improve its net margins, reduce debt, and smoothly integrate its latest acquisition, the stock's upside would be substantial. mark for My Articles similar articles
The Motley Fool
September 26, 2007
Ryan Fuhrmann
Foolish Forecast: Does Rite Aid Have the Right Rx? The retail pharmacy is set to release it second-quarter financial results. Investors, here is what you can expect to see. mark for My Articles similar articles
The Motley Fool
April 5, 2006
Rich Smith
Foolish Forecast: Rite Aid Writes a Script Although the retail pharmacy isn't setting the world on fire with its turnaround, its gross margins have inched up slightly over the last 18 months. Investors, take note. mark for My Articles similar articles
The Motley Fool
December 21, 2005
Stephen D. Simpson
No Short Circuit at Jabil A tech recovery and industry consolidation could boost this diversified electronic manufacturing services player. This company is worth further due diligence for investors who expect demand for all manner of electronics to stay healthy. mark for My Articles similar articles
The Motley Fool
June 29, 2007
Ryan Fuhrmann
Rite Aid's Recent Remedy Will increased market clout lead the drugstore operator to new highs? Investors, take note. mark for My Articles similar articles
The Motley Fool
July 6, 2004
Alyce Lomax
Not Ready for Rite Aid Can the drugstore chain hold a candle to the competition? Its shares are trading at 22 times forward earnings, making it a seemingly less-than-advantageous time to place a bet on them. mark for My Articles similar articles
The Motley Fool
September 29, 2011
Navjot Kaur
Should You Write Off Rite Aid? Rite Aid posts a relatively better quarter as wellness rewards the company. mark for My Articles similar articles
The Motley Fool
October 4, 2005
Seth Jayson
Same Old Same-Store Story Reports from Walgreen and Rite Aid confirm the obvious. Investors will nearly always do better buying the best company in any given space. mark for My Articles similar articles
The Motley Fool
December 24, 2007
Anders Bylund
3 Stocks That Missed the Mark These companies overpromised and underdelivered: Darden Restaurants... Rite Aid... Morgan Stanley... mark for My Articles similar articles
The Motley Fool
June 22, 2011
Anders Bylund
This Survivor Stock Deserves a Second Look Jabil takes a licking and keeps on kicking butt. What's not to love? mark for My Articles similar articles
The Motley Fool
June 21, 2006
Rich Smith
Foolish Forecast: Rite Aid Revival? Will tomorrow's earnings news make it three bad quarters in a row for the retail pharmacy? Investors, take note. mark for My Articles similar articles
The Motley Fool
April 9, 2010
Anders Bylund
Can TTM Technologies Buy Love? Yes, it can. In fact, the company keeps buying more of it. mark for My Articles similar articles
The Motley Fool
June 23, 2006
Ryan Fuhrmann
EMS Industry Woes Investing in the Electronic Component Manufacturing (ECM) space -- as the EMS industry is also known -- has been filled with landmines, especially for those overly exposed to the putrid telecom sector. mark for My Articles similar articles
The Motley Fool
June 14, 2004
Rick Aristotle Munarriz
Big Boxes' Big Earnings Consumer electronics retailers lead the list of weekly earnings reports. mark for My Articles similar articles
The Motley Fool
December 11, 2006
Matthew Crews
Rite Aid: Comps Mean Competition The pharmacy chain reported positive same-store results for November. Investors, take note. mark for My Articles similar articles
The Motley Fool
January 5, 2007
Matthew Crews
Rite Aid's Baby Steps If Rite Aid does manage 5% operating margins, this pharmacy chain's shares will get the love they deserve. mark for My Articles similar articles
The Motley Fool
December 21, 2011
Seth Jayson
Jabil Circuit Increases Sales but Misses Estimates Anyway For the quarter ended Nov. 30, Jabil Circuit missed slightly on revenues and met expectations on earnings per share. mark for My Articles similar articles
The Motley Fool
September 25, 2009
Chris Jones
The First Symptom of Health-Care Troubles? Rite Aid's problems imply bad news for consumers and the health-care system. mark for My Articles similar articles
The Motley Fool
December 16, 2004
Nathan Slaughter
Rx: Get Some Earnings Quick The No. 3 drug chain Rite Aid posts a sharp drop in earnings and slashes guidance again. mark for My Articles similar articles
The Motley Fool
June 11, 2007
Mike Cianciolo
Rite Aid's Generic Sales The drugstore chain gradually increases sales, and catches up to the big boys in one way. Investors, take note. mark for My Articles similar articles
The Motley Fool
January 4, 2005
Seth Jayson
Rite Aid Still Needs First Aid Sales keep slacking for this tough turnaround. This doesn't mean investors should necessarily jump ship. mark for My Articles similar articles
The Motley Fool
June 27, 2011
Shubh Datta
All Is Not Yet Right at Rite Aid Drug retailer Rite Aid posts losses in its first fiscal quarter and sees further losses ahead. mark for My Articles similar articles
The Motley Fool
September 27, 2006
Anders Bylund
Jabil Keeps Investors Waiting Options, beautiful options. Leave the finding of guilt to the SEC and our court system. In the meantime, Jabil shareholders can enjoy their newfound dividends and buybacks. mark for My Articles similar articles
The Motley Fool
January 3, 2005
Nathan Slaughter
Walgreen Seeing Green Rivals CVS and Rite Aid have a bitter pill to swallow as Walgreen stays strong. While Walgreen's revenues were in line with forecasts, the stronger-than-expected bottom line has the stock gaining ground. mark for My Articles similar articles
The Motley Fool
June 25, 2004
Steven Mallas
Rite Aid in the Shadows The first quarter for Rite Aid, the pharmaceutical retailer, shows a profit, but is it time to add this stock to your portfolio? mark for My Articles similar articles
The Motley Fool
September 26, 2006
Ryan Fuhrmann
Jaw-Dropping Pill-Popping at Walgreen How much longer can investors count on Walgreen's stellar numbers? mark for My Articles similar articles
The Motley Fool
April 14, 2008
Anders Bylund
3 Stocks That Missed the Mark These companies overpromised and underdelivered: Alcoa... Rite Aid... GE... mark for My Articles similar articles
The Motley Fool
June 22, 2006
Stephen D. Simpson
Rite Aid: Not Quite Rad, but Not All Bad Better results are possible, but there might be better ideas for investors. mark for My Articles similar articles
The Motley Fool
March 24, 2006
Stephen D. Simpson
Solectron Plays for Time The electronics manufacturer's appeal lies entirely in its future potential. This is not a good idea for anyone but the most risk-tolerant investors, but still, there's more potential here than the market wants to recognize today. mark for My Articles similar articles
The Motley Fool
September 22, 2010
Rich Smith
Foolish Forecast: A Prescription for Rite Aid Investors Here's what you need to know before earnings come out tomorrow. mark for My Articles similar articles
The Motley Fool
June 25, 2007
Ryan Fuhrmann
Foolish Forecast: Rite Aid Aims for Healthy Growth The drugstore operator is set to report its first-quarter earnings. Investors, here is what you can expect to see. mark for My Articles similar articles
The Motley Fool
July 19, 2010
Rick Aristotle Munarriz
4 Dividend Stocks Showing You the Money Companies with growing yields can make you rich in more ways than the obvious. mark for My Articles similar articles
The Motley Fool
February 4, 2008
Selena Maranjian
Best International Stock: Flextronics A quick summary of Singapore-based Flextronics, a contract manufacturer of components for electronics companies. mark for My Articles similar articles
InternetNews
September 29, 2009
Micron, Jabil Top Wall Street Forecasts Jabil and Micron see signs of improvement, but investors stay worried. mark for My Articles similar articles
The Motley Fool
September 27, 2007
Ryan Fuhrmann
Rite Aid Looks a Little Peaked Bigger doesn't necessarily mean better for the drugstore retailer; it has quite a bit of work to do to convince investors it can successfully manage the empire that it has acquired. mark for My Articles similar articles